“…However, there has recently been a flurry of renewed research activity using chemiluminescent 1,2-dioxetanes for cellular and in vivo imaging following demonstrations that these molecules were biocompatible and had bright enough emission for use in whole animal imaging. − Shabat and co-workers also introduced important structural modifications that increased quantum yield in aqueous systems without the need for polymeric encapsulation, , leading to improved applicability for bioanalysis and imaging. These innovations have enabled a new field of activity-based chemiluminescence imaging agents for analytes including galactosidase, phosphatase, proteases, tyrosinase, nitroreductase, ,, carboxyl esterase, H 2 S, , ONOO – , − H 2 O 2 , , HNO, HOCl, formaldehyde, pH, , a genetically engineered esterase/ester pair, and O 2 , , to name a few. − Central to advancing the capabilities of these types of 1,2-dioxetane imaging agents is understanding how modifications of the structural design impact the chemiluminescence properties including quantum yields, kinetics, and emission wavelengths. In this Perspective, we will do a selective survey of the landscape of triggerable 1,2-dioxetane structures and consider how their design features affect chemiluminescent properties.…”